|
|
|
|
Sputum Desmosine During Hospital Admission for Pulmonary Exacerbation in Cystic Fibrosis
Theresa A.Laguna , MD, MSCS, FCCP (lagun005{at}umn.edu), Brandie D. Wagner , PhD, Heidi K. Luckey , BS, Shelley A. Mann , RN, Scott D. Sagel , MD, Warren Regelmann , MD and Frank J. Accurso , MD From the Department of Pediatrics...
|
|
|
Link Between Common Antibacterial Treatment And Sensorineural Hearing Loss In Cystic Fibrosis Patients
Between Common Antibacterial Treatment And Sensorineural Hearing Loss In Patients Medical Medical Medical Worldwide Search / Oncology hip Funny Useful Websites details of 26,000 UK specialists medical software Ask a Doctor and Disease...
|
|
|
Obstructive Sleep Apnea Is Common in Idiopathic Pulmonary Fibrosis
Common in CHEST Keyword Search Search Guest Access Is Common in , MD, FCCP, , MSN, ACNP-BC, FCCP , BS, , MD, FCCP, , MD, , MD, FCCP, , MD, FCCP and , MD Division of Allergy, Pulmonary, and Critical Care Medicine (Drs.Lancaster, Rice, Loyd...
|
|
|
Shaky biotech partnerships haunt disease foundations
Disease foundations that are taking an increasing role in capital formation for local biotechs are nervously watching as the stock market and private capital markets wreak havoc with the companies that may hold the key to their future cures....
|
|
|
Link Between Common Antibacterial Treatment And Sensorineural Hearing Loss In Cystic Fibrosis Patients
An otherwise effective treatment for cystic fibrosis places patients at a high risk of sensorineural hearing loss, according to new research published in the July edition of Otolaryngology-Head and Neck Surgery.Cystic fibrosis...
|
|
|
Cystic Fibrosis Related Diabetes: Current Trends in Prevalence, Incidence and Mortality
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Diabetes Care, 07/02/09 Print Save in My Library Free Abstract Moran A et al.- Previously noted gender differences in mortality have disappeared, and the...
|
|
|
Cystic Fibrosis Treatment May Cause Hearing Loss
THURSDAY, July 2 (HealthDay News) -- A common antibacterial treatment for cystic fibrosis can cause sensorineural hearing loss, finds a new study.Researchers reviewed the medical records of 50 cystic fibrosis patients treated...
|
|
|
June 2009 Briefing - Critical Care
Here are what the editors at HealthDay consider to be the most important developments in Critical Care for June 2009.This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes...
|
|
|
June 2009 Briefing - Pulmonology
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for June 2009.This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes...
|
|
|
Safe And Successful Fertility Treatment Possible In Women With Cystic Fibrosis
Women with cystic fibrosis can have fertility treatment to help them have babies without any long-term adverse effects on either themselves or their children, according to new research presented at the 25th annual meeting of the...
|
|
|
Re: Lung Transplantation in Older Patients With Cystic Fibrosis: Analysis of UNOS Data
_ Re: Lung Transplantation in Older Patients With Cystic Fibrosis: Analysis of UNOS Data.
|
|
|
Nephrogenic Systemic Fibrosis And Gadolinium-Based Contrast Agents
Even at very high doses, gadolinium-based contrast agents alone are not sufficient to cause nephrogenic systemic fibrosis (NSF) in patients with kidney problems, according to a study performed at the Mayo Clinic Florida, Jacksonville, FL.
|
|
|
Pharmac To Fund Chlamydia Drug For Cystic Fibrosis Treatment
Wellington, June 30 NZPA - An antibiotic used to treat chlamydia will be funded for from tomorrow, Government Pharmac announced today.Treatment with anti-inflammatory drug azithromycin could reduce the number of hospital admissions and...
|
|
|
Interferon Gamma-1b No Help to Pulmonary Fibrosis Patients
TUESDAY, June 30 (HealthDay News) -- Treating idiopathic pulmonary fibrosis patients with interferon gamma-1b does not improve their chances of survival, according to a study published online June 30 in The Lancet.Talmadge E. King Jr.,...
|
|
|
Idiopathic Pulmonary Fibrosis
In The Lancet today, Talmadge King and colleagues report the results of the INSPIRE trial with interferon gamma-1b in idiopathic pulmonary fibrosis.1 The investigators randomised 826 patients to receive interferon gamma-1b or placebo in a...
|
|
|
Interferon No Help in Idiopathic Pulmonary Fibrosis
Patients with idiopathic pulmonary fibrosis do not benefit from treatment with interferon gamma-1b, according to a Lancet study released online.Researchers randomized some 800 patients with mild-to-moderate disease in an international,...
|
|
|
Survival Of Patients With Idiopathic Pulmonary Fibrosis (IPF) Does Not Improve With Interferon Gamma-1b Treatm
An article published Online First and in an upcoming edition of reports the findings of the INSPIRE trial on treatment of idiopathic pulmonary fibrosis (IPF) with interferon gamma-1b (Ifn-g1b).It is written by Professor Talmadge E King Jr...
|
|
|
Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
Company Also Receives Patent Covering ARIKACE for Once-Daily Treatment of Pseudomonas Lung Infections MONMOUTH JUNCTION, N.J., June 25 /PRNewswire/ -- Cystic Fibrosis Foundation Therapeutics Inc., the nonprofit affiliate of the ...
|
|
|
Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Journal of Cystic Fibrosis , 06/26/09 Print Save in My Library Free Abstract Cohen-Cymberknoh M et al.- High-dose IV-pulse methylprednisolone...
|
|
|
European CHMP Adopts Positive Opinion for Aztreonam Lysine
The CHMP's positive recommendation will be reviewed by the European Commission, which has the authority to approve medicinal products for use in the 27 countries of the European Union.Gilead expects the European Commission to issue its...
|
|
|
Gilead Sciences' Aztreonam Lysine For Cystic Fibrosis Receives Positive Opinion From European CHMP - Update
AM ET RELATED NEWS TOP MARKET NEWS (RTTNews) - Biopharmaceutical company Gilead Sciences, Inc.(GILD: News ) said Friday that its Marketing Authorisation Application for aztreonam lysine for cystic fibrosis received a positive...
|
|
|
CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week
SAN JOSE, Calif., June 25 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced today it has scheduled its 2009 National Pulmonary Fibrosis (PF) Awareness Week for September 14-21, 2009.The primary...
|
|
|
CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week
SAN JOSE, Calif., June 25 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced today it has scheduled its 2009 National Pulmonary Fibrosis (PF) Awareness Week for September 14-21, 2009.The primary...
|
|
|
CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week
2009 Awareness Efforts Set for August and September, PF Week Sept.14 - 21 SAN JOSE, Calif., June 25 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced today it has scheduled its 2009 National Pulmonary ...
|
|
|
Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
Company Also Receives Patent Covering ARIKACE for Once-Daily Treatment of Pseudomonas Lung Infections MONMOUTH JUNCTION, N.J., June 25 /PRNewswire/ -- Cystic Fibrosis Foundation Therapeutics Inc., the nonprofit affiliate of the ...
|
